D-0531-2025 Class II Ongoing

Recalled by Advanced Pharmaceutical Technology, Inc. — Elmsford, NY

FDA drug recall D-0531-2025 was initiated by Advanced Pharmaceutical Technology, Inc. on May 30, 2025 and is designated Class II. Reason for recall: Marketed Without an Approved NDA/ANDA The recall status is ongoing. Affected quantity: 26 vials.

Recall details

Product Type
Drugs
Report Date
Jul 2, 2025
Initiation Date
May 30, 2025
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
26 vials

Product description

TESTO-200, Testosterone Cypionate Inj. USP, 2000mg/10ml (200mg/ml), One 10ml multidose vial per carton, For intramuscular injection only, Rx Only, ADVANCED PHARMACEUTICAL TECHNOLOGY, INC., 132 South Central Avenue, Elmsford, NY 10523. NDC 57377-200-01

Reason for recall

Marketed Without an Approved NDA/ANDA

Distribution pattern

NY, NJ

Code information

Lot P-24-1; Exp. 02/28/2027

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0531-2025
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0531-2025. Report a data issue: hello@regdatalab.com.